Sign up to receive updates from Adaptive on our COVID-19 programs

By submitting this for you agree to the Join In Terms and Conditions and Privacy Policy.

Research Use Only. Not for use in diagnostic procedures.

Decoding the Immune Response to COVID-19

Adaptive is proud to partner with industry leaders to respond to this global health pandemic


At Adaptive, we are leveraging the immune system's natural ability to detect and treat disease to develop clinical products. Understanding the immune response to COVID-19 may lead to solutions to accelerate progress against the disease.

We are pursuing two seperate but synergistic applications of our immune medicine platform to combat COVID-19:

  • In March 2020, we extended our existing partnership with Microsoft to decode the immune system's response to COVID-19 and potentially develop a more sensitive diagnostic that can detect disease earlier or indicate who has been previously infected.
  • In April 2020, we announced a partnership with Amgen to leverage our platform's drug discovery capabilities to develop potential antibody therapies for COVID-19.

Sign up to receive updates from Adaptive on our COVID-19 programs.